Press Releases
September 29, 2025
Children’s Charity With Beyoncé’s Dad as Ambassador of Hope Celebrates New Children’s Book Release About Beating Cancer
Neutral
EIN Presswire
September 17, 2025
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
Indeterminate
GlobeNewswire, Inc.
October 29, 2025
Grammy Winner Q Parker Announces Sophomore Album 'Evolution Of Romance, Volume One' Arriving November 14th
Neutral
EIN Presswire
August 13, 2025
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
Indeterminate
GlobeNewswire, Inc.
October 27, 2025
Connecting AI, Digital Transformation, and Society: Inside Romania’s DIH4Society Initiative
Neutral
EIN Presswire
October 28, 2025
France Reportedly Plans Military Action in Ukraine
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
July 30, 2025
Immutep Quarterly Activities Report Q4 FY25
Indeterminate
GlobeNewswire, Inc.
October 28, 2025
Mondelēz International Reports Q3 2025 Results
Indeterminate
GlobeNewswire, Inc.
October 28, 2025
Moscow says Macron prepares to intervene militarily in Ukraine
Indeterminate
MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber
September 22, 2025
UC Connect Empowers Lewminous Skin to Deliver Client-First Service
Neutral
EIN Presswire
October 27, 2025
Savaria Announces Date for Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
September 19, 2025
Revenue Cycle Management Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Athenahealth, Cerner
Neutral
EIN Presswire
July 21, 2025
Triclinic Labs Appoints Joanna Bis, Ph.D., as Business Development Manager
Neutral
EIN Presswire
September 23, 2025
Joint statement: offer to assist with treatments of patients from Gaza in the Occupied West Bank, including East Jerusalem
Gov't Institution
Government of Slovenia
Owner: Slovenian Government
September 8, 2025
Dental Composites Market Size is Estimated to Reach US$ 171.3 Mn and Expanding at a CAGR of 8.6% by 2034 | TMR Research
Neutral
EIN Presswire
August 5, 2025
OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
Indeterminate
GlobeNewswire, Inc.
July 23, 2025
4TEEN4 Doses First Patient in Phase 1b/2a Trial of Procizumab, a Monoclonal Antibody Targeting the Biological Driver of Shock
Indeterminate
GlobeNewswire, Inc.